Ainos, Inc. (AIMD) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US00902F4028
Ainos, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 124,157.00 USD |
| Gross profit | 102,911.00 USD |
| Operating income | -13.99 m USD |
| EBIT | -14.06 m USD |
| Net income | -14.77 m USD |
| Diluted EPS – continuing operations | -3.46 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ainos, Inc.
Ainos, Inc., a dual-platform company, focusing artificial intelligencebased smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
More stocks
- Nixxy, Inc. (NIXX)
- INTEGRATED BIOPHARMA INC (INBP)
- DSS, INC. (DSS)
- ADDENTAX GROUP CORP. (ATXG)
- International Land Alliance Inc. (ILAL)
- CHEETAH NET SUPPLY CHAIN SERVICE INC. (CTNT)
- Quarta-Rad, Inc. (QURT)
- Elvictor Group, Inc. (ELVG)
- Processa Pharmaceuticals, Inc. (PCSA)
- Energys Group Limited Ordinary Shares (ENGS)
- Digerati Technologies, Inc. (DTGI)
- Superstar Platforms Inc. (SPST)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.